Publication Name	World Journal of Cardiology
Manuscript ID	7699
Country	Spain

Received	2013-12-02 17:32
Peer-Review Started	2013-12-03 10:44
To Make the First Decision	2013-12-13 13:25
Return for Revision	2013-12-14 17:32
Revised	2013-12-17 04:18
Second Decision	2014-01-20 08:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-01-20 10:01
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-03-04 04:11
Typeset the Manuscript	2014-03-10 16:29
Publish the Manuscript Online	2014-03-19 18:20

ISSN	1949-8462 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Minireviews
Article Title	Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era
Manuscript Source	Invited Manuscript
All Author List	Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez and Russel J Reiter
Funding Agency and Grant Number	Funding Agency Grant Number Framework of one research project of the Spanish Society of Cardiology for Clinical Research in Cardiology 2012
Corresponding Author	Alberto Dominguez-Rodriguez, MD, PhD, Department of Cardiology, Complejo Hospitalario Universitario de Canarias, Ofra s/n La Cuesta E-, 38320 Tenerife, Spain. adrvdg@hotmail.com
Key Words	ST-elevation myocardial infarction; Cardioprotection; Myocardial reperfusion injury; Infarct size; Adjunctive therapy
Core Tip	As therapeutic interventions administered at the time myocardial reperfusion have been proven to reduce infarct size in both experimental and clinical models, the existence of a lethal reperfusion injury and its contribution to ischemic cardiac cell death can no longer be ignored. Patients presenting with an acute ST-segment elevation myocardial infarction will likely benefit from therapy aimed at the timely administration of drugs, most likely via primary percutaneous coronary intervention, for the reduction/prevention of lethal reperfusion injury. This approach will ensure that patients maximally benefit from the myocardial salvage that results from these therapies.
Publish Date	2014-03-19 18:20
Citation	Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era. World J Cardiol 2014; 6(3): 100-106 Available from: URL: http://www.wjgnet. com/1949-8462/full/v6/i3/100.htm DOI: http://dx.doi. org/10.4330/wjc.v6.i3.100
URL	http://www.wjgnet.com/1949-8462/full/v6/i3/100.htm
DOI	http://dx.doi.org/10.4330/wjc.v6.i3.100

Full Article (PDF)	WJC-6-100.pdf
Full Article (Word)	WJC-6-100.doc
Manuscript File	7699-Review.doc
Answering Reviewers	7699-Answering reviewers.pdf
Copyright License Agreement	7699-Copyright assignment.pdf
Peer-review Report	7699-Peer review(s).pdf
Scientific Editor Work List	7699-Scientific editor work list.doc